IX logo

ORIX (IX) EBITDA

Annual EBITDA

$7.09 B
+$804.53 M+12.81%

31 March 2024

IX EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly EBITDA

N/A

01 September 2024

IX Quarterly EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

TTM EBITDA

N/A

01 September 2024

IX TTM EBITDA Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

IX EBITDA Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+12.8%--
3 y3 years+10.2%--
5 y5 years+0.1%--

IX EBITDA High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-11.9%+12.8%
5 y5 years-11.9%+12.8%
alltimeall time-11.9%+271.7%

ORIX EBITDA History

DateAnnualQuarterlyTTM
Mar 2024
$7.09 B(+12.8%)
$2.08 B(+16.4%)
$7.06 B(+3.6%)
Dec 2023
-
$1.79 B(+11.7%)
$6.82 B(+0.8%)
Sept 2023
-
$1.60 B(+0.9%)
$6.76 B(+3.9%)
June 2023
-
$1.59 B(-13.6%)
$6.51 B(+2.3%)
Mar 2023
$6.28 B(-21.9%)
$1.84 B(+5.9%)
$6.36 B(-9.4%)
Dec 2022
-
$1.73 B(+28.7%)
$7.02 B(+0.9%)
Sept 2022
-
$1.35 B(-6.5%)
$6.96 B(-8.5%)
June 2022
-
$1.44 B(-42.2%)
$7.60 B(-4.7%)
Mar 2022
$8.05 B(+25.2%)
$2.49 B(+49.2%)
$7.97 B(+12.3%)
Dec 2021
-
$1.67 B(-16.1%)
$7.10 B(-0.4%)
Sept 2021
-
$1.99 B(+9.8%)
$7.13 B(+6.5%)
June 2021
-
$1.81 B(+11.9%)
$6.69 B(+4.1%)
Mar 2021
$6.43 B(-14.4%)
$1.62 B(-4.4%)
$6.43 B(+1.3%)
Dec 2020
-
$1.70 B(+9.1%)
$6.35 B(-4.5%)
Sept 2020
-
$1.56 B(+0.1%)
$6.65 B(-8.3%)
June 2020
-
$1.55 B(+0.8%)
$7.25 B(-3.4%)
Mar 2020
$7.51 B(+6.1%)
$1.54 B(-22.9%)
$7.51 B(-4.3%)
Dec 2019
-
$2.00 B(-7.3%)
$7.85 B(+6.3%)
Sept 2019
-
$2.16 B(+19.1%)
$7.38 B(+4.8%)
June 2019
-
$1.81 B(-3.7%)
$7.04 B(-0.6%)
Mar 2019
$7.08 B(-1.0%)
$1.88 B(+22.7%)
$7.08 B(+4.0%)
Dec 2018
-
$1.53 B(-15.6%)
$6.81 B(-2.6%)
Sept 2018
-
$1.82 B(-1.8%)
$6.99 B(-0.2%)
June 2018
-
$1.85 B(+15.1%)
$7.01 B(-1.9%)
Mar 2018
$7.15 B(+2.9%)
$1.61 B(-6.1%)
$7.14 B(+0.3%)
Dec 2017
-
$1.71 B(-6.6%)
$7.12 B(-0.2%)
Sept 2017
-
$1.83 B(-7.7%)
$7.14 B(+0.6%)
June 2017
-
$1.99 B(+25.0%)
$7.10 B(+2.1%)
Mar 2017
$6.95 B(+17.6%)
$1.59 B(-8.0%)
$6.95 B(+5.9%)
Dec 2016
-
$1.73 B(-3.6%)
$6.57 B(+6.2%)
Sept 2016
-
$1.79 B(-2.6%)
$6.18 B(+1.9%)
June 2016
-
$1.84 B(+53.0%)
$6.07 B(+3.0%)
Mar 2016
$5.91 B(-0.0%)
$1.20 B(-10.5%)
$5.89 B(-1.9%)
Dec 2015
-
$1.34 B(-20.0%)
$6.00 B(+1.6%)
Sept 2015
-
$1.68 B(+1.0%)
$5.91 B(+0.8%)
June 2015
-
$1.66 B(+26.3%)
$5.86 B(-1.4%)
Mar 2015
$5.91 B(+2.8%)
$1.32 B(+5.2%)
$5.94 B(-7.2%)
Dec 2014
-
$1.25 B(-23.3%)
$6.40 B(-0.6%)
Sept 2014
-
$1.63 B(-6.4%)
$6.44 B(+5.0%)
June 2014
-
$1.74 B(-2.0%)
$6.14 B(+7.0%)
Mar 2014
$5.75 B
$1.78 B(+38.0%)
$5.74 B(+11.4%)
Dec 2013
-
$1.29 B(-2.8%)
$5.15 B(-2.3%)
Sept 2013
-
$1.33 B(-1.3%)
$5.28 B(-1.4%)
DateAnnualQuarterlyTTM
June 2013
-
$1.34 B(+12.6%)
$5.35 B(-2.1%)
Mar 2013
$5.46 B(+7.2%)
$1.19 B(-15.5%)
$5.47 B(+0.8%)
Dec 2012
-
$1.41 B(+0.6%)
$5.42 B(+3.7%)
Sept 2012
-
$1.40 B(-3.8%)
$5.23 B(+0.2%)
June 2012
-
$1.46 B(+27.1%)
$5.22 B(+2.6%)
Mar 2012
$5.09 B(+16.7%)
$1.15 B(-5.8%)
$5.09 B(+5.0%)
Dec 2011
-
$1.22 B(-12.5%)
$4.84 B(-0.4%)
Sept 2011
-
$1.39 B(+4.9%)
$4.87 B(+4.8%)
June 2011
-
$1.33 B(+46.9%)
$4.64 B(+6.3%)
Mar 2011
$4.36 B(+33.1%)
$904.03 M(-27.0%)
$4.37 B(+2.3%)
Dec 2010
-
$1.24 B(+5.8%)
$4.27 B(+9.3%)
Sept 2010
-
$1.17 B(+11.1%)
$3.91 B(+12.5%)
June 2010
-
$1.05 B(+30.8%)
$3.47 B(+5.7%)
Mar 2010
$3.28 B(+8.4%)
$806.81 M(-7.7%)
$3.28 B(+6.0%)
Dec 2009
-
$874.55 M(+18.7%)
$3.10 B(+28.6%)
Sept 2009
-
$736.51 M(-15.0%)
$2.41 B(-9.4%)
June 2009
-
$866.90 M(+39.8%)
$2.66 B(-10.2%)
Mar 2009
$3.02 B(-33.6%)
$620.22 M(+234.3%)
$2.96 B(-20.3%)
Dec 2008
-
$185.55 M(-81.2%)
$3.72 B(-18.6%)
Sept 2008
-
$987.11 M(-15.5%)
$4.56 B(-1.8%)
June 2008
-
$1.17 B(-15.0%)
$4.65 B(+1.2%)
Mar 2008
$4.55 B(-2.5%)
$1.38 B(+33.1%)
$4.59 B(+5.7%)
Dec 2007
-
$1.03 B(-3.3%)
$4.34 B(-5.9%)
Sept 2007
-
$1.07 B(-4.0%)
$4.62 B(-0.3%)
June 2007
-
$1.11 B(-1.4%)
$4.63 B(+9.2%)
Mar 2007
$4.67 B(+17.5%)
$1.13 B(-13.5%)
$4.24 B(+1.5%)
Dec 2006
-
$1.31 B(+20.6%)
$4.18 B(+10.3%)
Sept 2006
-
$1.08 B(+49.7%)
$3.78 B(+1.2%)
June 2006
-
$723.09 M(-32.1%)
$3.74 B(-6.2%)
Mar 2006
$3.97 B(+25.5%)
$1.06 B(+16.5%)
$3.99 B(+5.8%)
Dec 2005
-
$913.89 M(-11.8%)
$3.77 B(+1.6%)
Sept 2005
-
$1.04 B(+6.6%)
$3.71 B(+8.8%)
June 2005
-
$971.66 M(+14.8%)
$3.41 B(+7.0%)
Mar 2005
$3.16 B(+25.8%)
$846.65 M(-0.9%)
$3.19 B(+36.2%)
Dec 2004
-
$854.14 M(+15.9%)
$2.34 B(+57.5%)
Sept 2004
-
$736.90 M(-1.5%)
$1.48 B(+98.5%)
June 2004
-
$747.82 M
$747.82 M
Mar 2004
$2.52 B(+32.0%)
-
-
Mar 2003
$1.91 B(-14.9%)
-
-
Mar 2002
$2.24 B(-10.8%)
-
-
Mar 2001
$2.51 B(+10.5%)
-
-
Mar 2000
$2.27 B(+13.6%)
-
-
Mar 1999
$2.00 B(-8.0%)
-
-
Mar 1998
$2.17 B
-
-

FAQ

  • What is ORIX annual earnings before interest, taxes, depreciation & amortization?
  • What is the all time high annual EBITDA for ORIX?
  • What is ORIX annual EBITDA year-on-year change?
  • What is the all time high quarterly EBITDA for ORIX?
  • What is the all time high TTM EBITDA for ORIX?

What is ORIX annual earnings before interest, taxes, depreciation & amortization?

The current annual EBITDA of IX is $7.09 B

What is the all time high annual EBITDA for ORIX?

ORIX all-time high annual earnings before interest, taxes, depreciation & amortization is $8.05 B

What is ORIX annual EBITDA year-on-year change?

Over the past year, IX annual earnings before interest, taxes, depreciation & amortization has changed by +$804.53 M (+12.81%)

What is the all time high quarterly EBITDA for ORIX?

ORIX all-time high quarterly earnings before interest, taxes, depreciation & amortization is $2.49 B

What is the all time high TTM EBITDA for ORIX?

ORIX all-time high TTM earnings before interest, taxes, depreciation & amortization is $7.97 B